NCT03967977 2026-01-26
Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma
BeOne Medicines
Phase 3 Recruiting
BeOne Medicines
BeOne Medicines
PureTech
Abbisko Therapeutics Co, Ltd
Tianjin Medical University Second Hospital